Human iPSC-Derived Neural Stem Cells - Alzheimer's Disease Patient (APOE4 HOM)

560.00

Human iPSC-Derived Neural Stem Cells - Alzheimer's Disease Patient (APOE4 HOM). 1 vial of Neural Stem Cells (1.5 million cells) and 1 bottle of Neural Plating-XF Medium (30 mL).

Payment Options

We accept Visa and MasterCard in our online store.

Worldwide Shipping

We can get your cells to you wherever you are.

Customer Care

As an Axol customer you have access to our support team and product specialists.

Axol Human iPSC-Derived Neural Stem Cells

Axol Human iPSC-Derived Neural Stem Cells (NSCs) are derived from integration-free, induced pluripotent stem cells (iPSCs) under fully defined neural induction conditions. The NSCs express typical markers of cerebral cortical neural stem and progenitor cells such as PAX6, FOXG1 and nestin, and spontaneously form polarized neural tube-like rosette structures when plated as a monolayer in culture (see below). Additionally, Axol NSCs are capable of generating a spectrum of cerebral cortical excitatory and inhibitory neurons that are electrically active and have the ability to form functional synapses and circuits in vitro. After thawing and plating, the neural stem cells terminally differentiate to acquire mature electrophysiological properties, and form functional synaptic networks over a period of 40 ~ 50 days.

Axol NSCs are easy to differentiate to neurons or mixed neural cell types, following our protocols and using our tailored media and reagent bundles. A highly pure population of neurons can be generated from Axol NSCs following the synchronous differentiation protocol. Using our specialized coating reagents, neurons derived from Axol NSCs can be maintained in culture long-term (>1 year). NSCs are available from multiple donors to suit your research needs and have been characterized extensively.

Click here to see the data on Axol Neural Stem Cells
Starting material Dermal fibroblast
Donor gender Female
Donor age at sampling 87 yrs
HLA serotype A2 A68, B13(Bw4) B49(Bw4), Cw6 Cw7
Reprogramming method Episomal vector
Induction method Monolayer & chemically defined medium
Genetic modification None
Size ≥1.5 million cells
Kit components 1 vial of Neural Stem Cells (≥1.5 million cells) and 1 bottle of Neural Plating-XF Medium (30 mL)
Cell type iPSC-derived neural stem cells
Growth properties Adherent
Mutation APOE4 homozygous
Disease information The donor (Caucasian) had autopsy-confirmed Alzheimer's Disease with an onset of symptoms after age 70. The donor's parent and 3 siblings were also affected. The donor was homozygous for the 4 allele of apolipoprotein E.
Shipping conditions Dry ice
Storage conditions Liquid nitrogen
  • Read nowJones VC, Atkinson-Dell R, Verkhratsky A et al., Aberrant iPSC-derived human astrocytes in Alzheimer's disease. Cell Death and Disease (2017)